Cargando…
Low Dose Methotrexate and Vinblastine, Given Weekly to Patients With Desmoid Tumours, is Associated With Major Toxicity
Purpose: To evaluate the tolerance of a low dose chemotherapy regimen for desmoid tumours. Patients and methods: Patients with desmoids for whom radical resection was impossible or related to extensive mutilation were treated with chemotherapy. Treatment consisted of intravenous methotrexate at a do...
Autores principales: | van der Hul, René L., Seynaeve, Caroline, van Geel, Bert N., Verweij, Jaap |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2395524/ https://www.ncbi.nlm.nih.gov/pubmed/18521380 http://dx.doi.org/10.1080/13577140310001644779 |
Ejemplares similares
-
Desmoid with biweekly methotrexate and vinblastine shows similar effects to weekly administration: A phase II clinical trial
por: Nishida, Yoshihiro, et al.
Publicado: (2020) -
Tolerability and Efficacy of Neoadjuvant Chemotherapy with a Tri-Weekly Interval Methotrexate, Doxorubicin, Vinblastine, and Cisplatin Regimen for Patients with Locally Advanced Bladder Cancer
por: Arai, Satoko, et al.
Publicado: (2018) -
Desmoid Tumour of the Brachial Plexus
por: Juliette, Orege, et al.
Publicado: (2013) -
Invasion and MMP expression profile in desmoid tumours
por: Denys, H, et al.
Publicado: (2004) -
A randomized trial comparing methotrexate and vinblastine (MV) with cisplatin, methotrexate and vinblastine (CMV) in advanced transitional cell carcinoma: results and a report on prognostic factors in a Medical Research Council study. MRC Advanced Bladder Cancer Working Party.
por: Mead, G. M., et al.
Publicado: (1998)